Feline immunodeficiency virus-based lentiviral vectors

Cold Spring Harbor Protocols

Volumn 7, Issue 1, 2012, Pages 71-76

  Saenz, Dyana T ^a   Barraza, Román ^a   Loewen, Nils ^a   Teo, Wulin ^a   Poeschla, Eric M ^a  

^a CSHL Press ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; TRIPARTITE MOTIF PROTEIN 5;

ARTICLE; FELINE IMMUNODEFICIENCY VIRUS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; INTERNAL RIBOSOME ENTRY SITE; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NONHUMAN; OPEN READING FRAME; PROMOTER REGION; VESICULAR STOMATITIS VIRUS; VIRUS LIKE AGENT; VIRUS REPLICATION; CELL CULTURE; GENE VECTOR; GENETIC TRANSFORMATION; GENETICS; HUMAN; REVIEW;

CELLS, CULTURED; GENETIC VECTORS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; TRANSFORMATION, GENETIC;

EID: 84255189969     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.ip067579     Document Type: Article

References (53)

1. Alisky JM, Hughes SM, Sauter SL, Jolly D, Dubensky TW Jr, Staber PD, Chiorini JA, Davidson BL. 2000. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11: 2669-2673.
2. Berthoux L, Sebastian S, Sokolskaja E, Luban J. 2004. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J Virol 78: 11739-11750.
3. Besnier C, Takeuchi Y, Towers G. 2002. Restriction of lentivirus in monkeys. Proc Natl Acad Sci 99: 11920-11925.
4. Besnier C, Ylinen L, Strange B, Lister A, Takeuchi Y, Goff SP, Towers GJ. 2003. Characterization of murine leukemia virus restriction in mammals. J Virol 77: 13403-13406.
5. Brooks AI, Stein CS, Hughes SM, Heth J, McCray PM Jr, Sauter SL, Johnston JC, Cory-Slechta DA, Federoff HJ, Davidson BL. 2002. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci 99: 6216-6221.
6. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci 90: 8033-8037.
7. Curran MA, Nolan GP. 2002a. Nonprimate lentiviral vectors. Curr Top Microbiol Immunol 261: 75-105.
8. Curran MA, Nolan GP. 2002b. Recombinant feline immunodeficiency virus vectors. Preparation and use. Methods Mol Med 69: 335-350.
9. Curran MA, Kaiser SM, Achacoso PL, Nolan GP. 2000. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther 1: 31-38.
10. Curran MA, Ochoa MS, Molano RD, Pileggi A, Inverardi L, Kenyon NS, Nolan GP, Ricordi C, Fenjves ES. 2002. Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors. Transplantation 74: 299-306.
11. Derksen TA, Sauter SL, Davidson BL. 2002. Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection. J Gene Med Curran MA, Nolan GP 463-469.
12. Donello JE, Loeb JE, Hope TJ. 1998. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72: 5085-5092.
13. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
14. Elder JH, Phillips TR. 1995. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv Virus Res 45: 225-247.
15. Haskell RE, Hughes SM, Chiorini JA, Alisky JM, Davidson BL. 2003. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene,TPP-I to themouse central nervous system. Gene Ther 10: 34-42.
16. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ. 2003. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 22: 385-394.
17. Hope T. 2002. Improving the post-transcriptional aspects of lentiviral vectors. Curr Top Microbiol Immunol 261: 179-189.
18. Hughes SM, Moussavi-Harami F, Sauter SL, Davidson BL. 2002. Viralmediated gene transfer to mouse primary neural progenitor cells. Mol Ther 5: 16-24.
19. Johnston JC, Gasmi M, Lim LE, Elder JH, Yee JK, Jolly DJ, Campbell KP, Davidson BL, Sauter SL. 1999. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 73: 4991-5000.
20. Kang Y, Stein CS, Heth JA, Sinn PL, Penisten AK, Staber PD, Ratliff KL, Shen H, Barker CK, Martins I, et al. 2002. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 76: 9378-9388.
21. Kemler I, Barraza R, Poeschla EM. 2002. Mapping of the encapsidation determinants of feline immunodeficiency virus. J Virol 76: 11889-11903.
22. Kemler I, Azmi I, Poeschla EM. 2004. The critical role of proximal gag sequences in feline immunodeficiency virus genome encapsidation. Virology 327: 111-120.
23. Loewen N, Fautsch M, Peretz M, Bahler C, Cameron JD, Johnson DH, Poeschla EM. 2001. Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther 12: 2109-2119.
24. Loewen N, Bahler C, Teo W, Whitwam T, Peretz M, Xu R, Fautsch M, Johnson DH, Poeschla EM. 2002. Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Investig Ophthalmol Vis Sci 43: 3686-3690.
25. Loewen N, Barraza R, Whitwam T, Saenz D, Kemler I, Poeschla E. 2003a. FIV vectors. Methods Mol Biol 229: 251-271.
26. Loewen N, Leske D, Chen Y, Teo W, Saenz D, Peretz M, Holmes J, Poeschla EM. 2003b. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J Gene Med 5: 1009-1017.
27. Lotery AJ, Derksen TA, Russell SR, Mullins RF, Sauter S, Affatigato LM, Stone EM, Davidson BL. 2002. Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Hum Gene Ther 13: 689-696.
28. Lu R, Nakajima N, Hofmann W, Benkirane M, Jeang KT, Sodroski J, Engelman A. 2004. Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages. J Virol 78: 658-668.
29. Naldini L, Bloemer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
30. Parolin C, Sodroski J. 1995. A defective HIV-1 vector for gene transfer to human lymphocytes. J Mol Med 73: 279-288.
31. Pedersen NC. 1993. The feline immunodeficiency virus. In The Retroviridae (ed. Levy JA), pp. 181-228. Plenum Press, New York.
32. Poeschla E, Looney D. 1998. CXCR4 is required by a non-primate lentivirus: Heterologous expression of feline immunodeficiency virus in human, rodent and feline cells. J Virol 72: 6858-6866.
33. Poeschla E, Wong-Staal F, Looney D. 1998. Efficient transduction of nondividing cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4: 354-357.
34. Price MA, Case SS, Carbonaro DA, Yu XJ, Petersen D, Sabo KM, Curran MA, Engel BC, Margarian H, Abkowitz JL, et al. 2002. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther 6: 645-652.
35. Richmond YS, McKinney RW, eds. 1999. Biosafety in microbiological and biomedical laboratories (BMCL), 4th edition US Department of Health and Human Services, Public Health Service & Centers for Disease Control and Prevention, National Institutes of Health US Government Printing Office, Washington, DC.
36. Saenz DT, Poeschla EM. 2004. FIV: From lentivirus to lentivector. J Gene Med 16: S95-S104.
37. Saenz D, Loewen N, Peretz M, Whitwam T, Barraza R, Howell K, Holmes JH, Good M, Poeschla EM. 2004. Unintegrated lentiviral DNA persistence and accessibility to expression in nondividing cells: Analysis with class I integrase mutants. J Virol 78: 2906-2920.
38. Saenz D, Teo I, Olsen JC, Poeschla E. 2005. Restriction of feline immunodeficiency virus by Ref1, LV1 and primate TRIM5 proteins. J Virol 79: 15175-15188.
39. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. 2012a. Production and harvest of feline immunodeficiency virus-based lentiviral vector from cells grown in T75 tissue-culture flasks. Cold Spring Harb Protoc doi: 10.1101/pdb.prot067553.
40. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. 2012b. Production, harvest, and concentration of feline immunodeficiency virus-based lentiviral vector from cells grown in CF10 or CF2 devices. Cold Spring Harb Protoc doi: 10.1101/pdb.prot067546.
41. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. 2012c. Titration of feline immunodeficiency virus-based lentiviral vector preparations. Cold Spring Harb Protoc doi: 10.1101/pdb.prot067561.
42. Shaw G, Morse S, Ararat M, Graham FL. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16: 869-871.
43. Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL, Sanders DA, McCray PB Jr. 2003. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77: 5902-5910.
44. Stein CS, Davidson BL. 2002. Gene transfer to the brain using feline immunodeficiency virus-based lentivirus vectors. Methods Enzymol 346: 433-454.
45. Stein CS, Kang Y, Sauter SL, Townsend K, Staber P, Derksen TA, Martins I, Qian J, Davidson BL, McCray PB Jr, 2001. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol Ther 3: 850-856.
46. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5 restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
47. Towers G, Collins M, Takeuchi Y. 2002. Abrogation of Ref1 retrovirus restriction in human cells. J Virol 76: 2548-2550.
48. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435: 646-651.
49. Vargas J Jr, Gusella GL, Najfeld V, Klotman ME, Cara A. 2004. Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther 15: 361-372.
50. Wang G, Slepushkin V, Zabner J, Keshavjee S, Johnston JC, Sauter SL, Jolly DJ, Dubensky TW Jr, Davidson BL, McCray PB Jr, 1999. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect (see comments). J Clin Invest 104: R55-62.
51. Whitwam T, Peretz M, Poeschla EM. 2001. Identification of a central DNA flap in feline immunodeficiency virus. J Virol 75: 9407-9414.
52. Wu Y, Marsh JW. 2001. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293: 1503-1506.
53. Zufferey R, Donello JE, Trono D, Hope TJ. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886-2892.